Veradigm (formerly Allscripts)

Veradigm, which rebranded from Allscripts in 2023, is a healthcare technology company providing ambulatory EHR, practice management, and data analytics solutions to physician practices, health systems, and life sciences organizations. The company serves over 180,000 physicians across more than 2,500 hospitals and 13,000 post-acute organizations, making it one of the most established vendors in the healthcare IT space with a 37-year operating history.

The platform's core offering includes Veradigm Professional EHR (formerly Allscripts Professional), Veradigm Practice Fusion (a cloud-based EHR acquired in 2018), and TouchWorks EHR for larger enterprises. The dual product strategy positions Veradigm uniquely in serving both small independent practices seeking affordable cloud solutions and large multi-specialty groups requiring strong enterprise functionality. Practice Fusion, offered as a freemium model with revenue generated through health plan and life sciences partnerships, has attracted over 112,000 providers, while Professional and TouchWorks serve practices requiring deeper customization and workflow optimization.

Veradigm differentiates through its extensive healthcare data network, aggregating clinical and claims data from its installed base to power analytics, quality reporting, and real-world evidence generation for pharmaceutical and payer clients. This data monetization strategy creates a business model less dependent solely on software licensing compared to competitors. The company's CommonWell and Carequality participation enables broad interoperability, while native integrations with major lab systems, e-prescribing networks, and billing clearinghouses reduce implementation friction.

Deployment options include cloud-hosted SaaS for Practice Fusion users, private cloud hosting for Professional EHR customers, and on-premise installations for enterprise TouchWorks clients, though the company has been actively migrating customers to hosted models. The platform supports MIPS/MACRA reporting, value-based care workflows, and population health management through integrated analytics tools.

Target markets span solo practitioners to 100+ provider groups across primary care and specialty practices. The company particularly emphasizes family medicine, internal medicine, pediatrics, cardiology, behavioral health, and urgent care with specialty-specific templates and clinical content. Recent financial challenges, including declining software revenues and debt restructuring in 2023, have raised questions about long-term viability, though the company's established customer base and pivot toward data services provide potential stability. Practices evaluating Veradigm should weigh its mature feature set and integration ecosystem against concerns about financial health and slower innovation cycles compared to newer competitors like athenahealth and DrChrono.